97 related articles for article (PubMed ID: 7826982)
21. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer.
Huang J; Bay BH; Tan PH
Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377
[TBL] [Abstract][Full Text] [Related]
22. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.
Martín de las Mulas J; Van Niel M; Millán Y; Ordás J; Blankenstein MA; Van Mil F; Misdorp W
Res Vet Sci; 2002 Apr; 72(2):153-61. PubMed ID: 12027597
[TBL] [Abstract][Full Text] [Related]
23. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
24. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
25. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
26. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME
Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137
[TBL] [Abstract][Full Text] [Related]
27. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
28. Comparison of HER-2/neu, ER and PCNA expression in premenopausal and postmenopausal patients with breast carcinoma.
Zheng W; Zheng J; Ma L; Meng F; Huang L; Ma D
APMIS; 2005 Mar; 113(3):175-81. PubMed ID: 15799760
[TBL] [Abstract][Full Text] [Related]
29. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters.
Thike AA; Chng MJ; Fook-Chong S; Tan PH
Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor expression of benign breast epithelium and its association with breast cancer.
Khan SA; Rogers MA; Obando JA; Tamsen A
Cancer Res; 1994 Feb; 54(4):993-7. PubMed ID: 8313390
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
35. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
Skasko E; Paszko Z; Mazur S
Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors].
Sundblad AS; Caprarulo L
Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572
[TBL] [Abstract][Full Text] [Related]
37. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol.
Khan SA; Sachdeva A; Naim S; Meguid MM; Marx W; Simon H; Halverson JD; Numann PJ
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):867-72. PubMed ID: 10548314
[TBL] [Abstract][Full Text] [Related]
38. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
39. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of receptors for oestrogen and progesterone in endometrial glands and stroma during the oestrous cycle in Nelore (Bos taurus indicus) cows.
Martin I; Torres Neto R; Oba E; Buratini J; Binelli M; Laufer-Amorim R; Ferreira JC
Reprod Domest Anim; 2008 Aug; 43(4):415-21. PubMed ID: 18179635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
